YD Life Science has signed a technology transfer agreement with Korea Research Institute of Bioscience & Biotechnolo...
The healthcare robotics company Exosystems will soon be conducting a trial run of its ICT muscular rehabilitation soluti...
Basil D’Souza, Head of Korea Operations, Cactus Communications, was recently appointed as the Chair of External Af...
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) and the Korea Health Industry Development Inst...
Orgenesis, a manufacturer, service provider and developer of advanced cell therapies, has announced that Kangstem Biotec...
GC Pharma (formerly known as Green Cross) has announced that it has received approval from the South Korean Ministry of ...
Korea's Hironic, a medical device manufacturer specializing in skin care, announced on the 15th that Afit, an acne treat...
Celltrion, a leading biopharmaceutical company headquartered in Incheon, Korea has signed an ‘Incubation’ ag...
Inovio Pharmaceuticals and Korea's GeneOne Life Science have announced that they have dosed the first patient in a Phase...
The Korean government has approved Ono Pharma Korea and Bristol-Myers Squibb Korea to sell Opdivo (nivolumab)-Yervoy (ip...
A team of researchers at the Korea Advanced Institute of Science and Technology (KAIST) in South Korea has developed a f...
Medytox has said that it has filed a biologics license application with the Taiwan Food and Drug Administration for the ...
Korea-based ViroMed announced the acquisition of a plasmid DNA production facility in San Diego, California&n...
Singapore- Novartis has appointed the former chief of its Asia Pacific operations, Joshi Venugopal, as interim CEO of it...
Singapore - Cellect Biotechnology, a developer of a novel stem cell production technology, announced that it has si...
Cellect Biotechnology Ltd., a developer of a novel stem cell production technology, has received a Notice of Allowance f...
Daewoong Pharmaceutical has received sales approval for Nabota, its botulinum toxin (BTX) product to treat forehead wrin...
Macrogen, Inc., a precision medicine biotechnology company has announced that its two next generation sequencing (NGS) c...
